<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>794</id><JournalTitle>AKT ACTIVATION AND GSK-3Î² INACTIVATION IN THE HIPPOCAMPUS ARE ACCELERATED BY DELETING IL-33</JournalTitle><Abstract>The present study investigated the role of inteleukin-33 (IL-33), a proinflammatory cytokine, in the activities of Akt and glycogen synthase kinase 3Î² (GSK-3Î²). GSK-3Î² phosphorylates tau protein, causing neurofibrillary tangles (NFT) in the brain of Alzheimerâ€™s disease (AD). The IL-33 protein levels in the hippocampus of 5xFAD mice, an animal model of AD, were significantly higher than the levels for wild-type control mice. Ser473 phosphorylation of Akt and Ser9 phosphorylation of GSK-3Î² were significantly enhanced in the hippocampus of IL-33-deficient mice as compared with those for wild-type control mice. This indicates that Akt is more activated and GSK-3Î² is more inactivated by deleting IL-33; i.e., IL-33 inactivates Akt and activates GKS-3Î², thereby stimulating tau phosphorylation and NFS formation. Overall, these results raise the possibility that IL-33 may be a factor to accelerate tau phosphorylation in the AD brain.</Abstract><Email>tnishizaki@bioresorganization.com</Email><articletype>Research</articletype><volume>8</volume><issue>4</issue><year>2017</year><keyword>IL-33-deficient mouse, Akt, GSK-.</keyword><AUTHORS>Tomoyuki Nishizaki</AUTHORS><afflication>Tomoyuki Nishizaki</afflication></Article></Articles>